...
首页> 外文期刊>Luminescence: The journal of biological and chemical luminescence >Direct competitive chemiluminescence immunoassays based on gold-coated magnetic particles for detection of chloramphenicol
【24h】

Direct competitive chemiluminescence immunoassays based on gold-coated magnetic particles for detection of chloramphenicol

机译:基于包金磁性颗粒的直接竞争化学发光免疫分析法用于氯霉素的检测

获取原文
获取原文并翻译 | 示例

摘要

Direct competitive chemiluminescence immunoassays (CLIA) based on gold-coated magnetic nanospheres (Au-MNPs) were developed for rapid analysis of chloramphenicol (CAP). The Au-MNPs were modified with carboxyl groups and amino groups by 11-mercaptoundecanoic acid (MUA) and cysteamine respectively, and then were respectively conjugated with CAP base and CAP succinate via an activating reaction using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS). NSP-DMAE-NHS, a new and effective luminescence reagent, was employed to label anti-CAP antibody (mAb) as a tracer in direct CLIA for CAP detection using a 'homemade' luminescent measurement system that was set up with a photomultiplier tube (PMT) and a photon counting unit linked to a computer. The sensitivities and limits of detection (LODs) of the two methods were obtained and compared according to the inhibition curves. The 50% inhibition concentration (IC50) values of the two methods were about 0.044 ng/mL and 0.072 ng/mL respectively and LODs were approximately 0.001 ng/mL and 0.006 ng/mL respectively. To our knowledge, they were much more sensitive than any traditional enzyme-linked immunosorbent assay (ELISA) ever reported. Moreover, the new luminescence reagent NSPDMAE-NHS is much more sensitive and stable than luminol and its derivatives, contributing to the sensitivity enhancement. Copyright (C) 2015 John Wiley & Sons, Ltd.
机译:基于金包被的磁性纳米球(Au-MNPs)的直接竞争化学发光免疫分析法(CLIA)被开发用于氯霉素(CAP)的快速分析。用11-巯基十一酸(MUA)和半胱胺分别修饰Au-MNP的羧基和氨基,然后通过1-乙基-3-(3-二甲基氨基丙基)的活化反应分别与CAP碱和琥珀酸CAP偶联。 )碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)。 NSP-DMAE-NHS是一种新型且有效的发光试剂,被用来标记抗CAP抗体(mAb)作为直接CLIA中的示踪剂,用于通过使用装有光电倍增管的``自制''发光测量系统进行CAP检测。 PMT)和与计算机链接的光子计数单元。获得了两种方法的灵敏度和检测限(LOD),并根据抑制曲线进行了比较。两种方法的50%抑制浓度(IC50)值分别约为0.044 ng / mL和0.072 ng / mL,LOD分别约为0.001 ng / mL和0.006 ng / mL。据我们所知,它们比任何传统的酶联免疫吸附测定(ELISA)都要灵敏得多。此外,新型发光试剂NSPDMAE-NHS比鲁米诺及其衍生物更加灵敏和稳定,有助于提高灵敏度。版权所有(C)2015 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号